Tominaga T
Dept. of Surgery, Tokyo Metropolitan Komagome Hospital, Japan.
Gan To Kagaku Ryoho. 1996 May;23(6):678-83.
Recently, new hormonal drugs such as aromatase inhibitor, LHRH and analogue and the derivative of tamoxifen have been introduced clinically into treatment of breast cancer. Combined therapies not only with a variety of hormonal drugs but with anti-cancer drugs are under consideration and superior results are expected.
